Spectracef Side Effects
Please note - some side effects for Spectracef may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
Side Effects of Spectracef - for the Consumer
Spectracef
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Spectracef:
Seek medical attention right away if any of these SEVERE side effects occur when using Spectracef:Headache; mild diarrhea; nausea; stomach pain or upset; vomiting.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody stools; decreased urination; easy bruising or bleeding; fever; hoarseness; red, swollen, or blistered skin; seizures; severe diarrhea; severe nausea or vomiting; severe stomach pain/cramping; unusual tiredness; vaginal discharge or itching; white spots in the mouth; yellowing of the skin or eyes.
Side Effects by Body System
General
In clinical trials, cefditoren pivoxil has been well tolerated. Most adverse effects were mild and self-limiting, and the overall incidence was higher with increased dosage.
Gastrointestinal
Gastrointestinal adverse effects reported include diarrhea (11% to 15%), nausea (4% to 6%), abdominal pain (2%), dyspepsia (1% to 2%), and vomiting (1%). Flatulence, pseudomembranous colitis, oral moniliasis, anorexia, constipation, dry mouth, eructation, flatulence, gastrointestinal disorder, increased appetite, stomatitis, and taste perversion have been reported in less than 1% of patients.
Dermatologic
Dermatologic side effects have included pruritus, rash, and urticaria in less than 1% of patients. Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis have also been reported.
Hypersensitivity
Hypersensitivity adverse effects reported for cephalosporins include allergic reactions, anaphylaxis, Stevens-Johnson syndrome, serum sickness-like reaction, toxic epidermal necrolysis, and erythema multiforme. Patients allergic to other beta-lactam antibiotics may be allergic to cefditoren.
Genitourinary
Genitourinary adverse effects have included vaginal moniliasis (3% to 6%), leukorrhea (less than 1%), and vaginitis (less than 1%).
Hepatic
Hepatic adverse effects have included abnormal liver function tests (less than 1%). Cephalosporins as a class have been associated with hepatic dysfunction including cholestasis.
Hematologic
Hematologic side effects have included increased coagulation time, thrombocythemia, leukopenia, and thrombocytopenia in less than 1% of patients. Cephalosporins as a class have been associated with aplastic anemia, hemolytic anemia, hemorrhage, neutropenia, pancytopenia, and agranulocytosis.
Nervous system
Nervous system side effects have included headache (2% to 3%); insomnia, nervousness, asthenia, somnolence, and dizziness (less than 1%). Some cephalosporins have been associated with seizures in renally impaired patients.
Metabolic
Metabolic side effects have included hyperglycemia and thirst in less than 1% of patients. Pivalate-containing compounds have been associated with clinically significant carnitine deficiency during prolonged use due to increased renal excretion of carnitine. Short-term treatment of cefditoren pivoxil has not been associated with clinical effects of decreased carnitine levels.
Thirty percent and 46% decreases in serum carnitine levels were reported in patients after cefditoren 200 mg twice daily for 14 days and 400 mg twice daily for 14 days, respectively. Carnitine levels normalized within 7 days after discontinuation.
Renal
Renal side effects have included acute renal failure. Cephalosporins as a class have been associated with renal dysfunction and toxic nephropathy.
Respiratory
Respiratory side effects have rarely included asthma, pharyngitis, rhinitis, sinusitis, interstitial pneumonia, and acute eosinophilic pneumonia.
Musculoskeletal
Musculoskeletal side effects have included arthralgia and myalgia (less than 1%).
Psychiatric
Psychiatric side effects have included abnormal dreams.
Endocrine
Endocrine side effects have included sweating (less than 1%).
Other
Other side effects have included face edema, fungal infection, peripheral edema, and pain in less than 1% of patients.
TopMore resources:
Spectracef - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
